Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Response to Dr Hungerford
Dahl, Jordi S. , Ali, Mulham , Pîbarot, Philippe , Clavel, Marie‐Annick , Dahl, Jordi S , Pibarot, Phillippe , Clavel, Marie-Annick

European Heart Journal - Cardiovascular Imaging | July 2, 2025 | Volume: 26 | Issue: 9 | Pages: 1598-1598

10.1093/ehjci/jeaf192 | PMID 40601815 Get It

eLife Assessment: Genetic compensation in podocalyxin-like mutants during zebrafish liver development
Ekker, Stephen C.

No container title available | July 2, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.106460.1.sa4 Get It

Reply: Interpreting real-world data in advanced HCC—Need for clarity on subsequent therapies, adverse events, and follow-up adequacy
Ahn, Joseph , Ng, Wee Han , Yeo, Yee Hui , Singal, Amit G. , Yang, Ju Dong , Ahn, Joseph C , Singal, Amit , Yang, Ju Dong

Hepatology | July 2, 2025 | Volume: 83 | Issue: 2 | Pages: E84-E85

10.1097/hep.0000000000001448 | PMID 40601291 Get It

Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations
Hoydonckx, Yasmine , Feoktistov, Alexander, Amoozegar, Farnaz , Anderson, C. , Barad, Meredith , Burke, Emeralda , Chitsantikul, Prin, Doshi, Tina L , Englesakis, Marina , Goel, Akash , Gupta, Himanshu , Kirschner, Abby, Kohan, Lynn , Lauritsen, Clinton G. , Miller, Franziska , Monsour, Danny, Nader, Antoun , Ogunlaja, Oyindamola, Silberstein, Stephen D., Souza, Dmitri , Kohan, Lynn R , Nader, Antoun , Schwenk, Eric S , Yuan, Hsiangkuo , Englesakis, Marina , Doshi, Tina L , Barad, Meredith J , Gupta, Himanshu, Kissoon, Narayan , Schuster, Nathaniel M. , Schwenk, Eric S. , Yuan, Hsiangkuo , Narouze, Samer

Regional Anesthesia & Pain Medicine | July 2, 2025 | Volume: 51 | Issue: 2 | Pages: 117-131

10.1136/rapm-2025-106718 | PMID 40602807 Get It

Introduction Patients hospitalized for headache treatment pose unique challenges to the healthcare system. Currently, there is a lack of evidence-based guidance on management. This practice advisory aims to fill this critical gap by systematically reviewing the existing literature and providing comprehensive, evidence-based recommendations for managing headache patients during hospitalization. Methods In February 2023, the American Society of Regional Anesthesia and Pain Medicine approved this practice advisory proposal. The steering committee selected committee members based on clinical and research expertise in the field of headache medicine. Nine questions were formulated by the committee, and each question was assigned to a group composed of 3–4 members. A systematic literature search for each question was performed in Medline, Embase, Cochrane Database of Systematic Reviews and Web of Science on June 21, 2023. The results from each search were imported into separate Covidence projects for screening, data extraction, and risk of bias assessment. Additionally, relevant systematic reviews (SR) were screened. Each group submitted a structured narrative review along with statements and recommendations based on the US Preventive Services Task Force (USPSTF) format for grading of evidence. While the USPSTF framework was used, including the language in the recommendations, the formal USPSTF methodology, including the SR with meta-analysis and summary tables with forest plots, was not followed because of low overall evidence quality. The interim draft was shared electronically with each collaborator, who was requested to vote anonymously using two rounds of the modified Delphi approach. A consensus recommendation required >75% agreement. Results The panel generated 12 statements and 17 recommendations, along with their strength and certainty of evidence. Following two rounds of Delphi voting, a high consensus was achieved for all statements and recommendations. Most statements received a low-to-moderate level of certainty, and all but one recommendation received grade B or C, which was consistent with the lack of randomized controlled trials supporting most of the drugs in this document. Conclusions This evidence-based practice advisory provides a foundational step toward standardizing inpatient headache care and highlights existing gaps in the literature that should be addressed through rigorous prospective randomized studies.
Bloating and Distention Patients Form 6 Distinct Latent Clusters Based on Symptoms, Diet, Psychosocial, and Quality-of-Life Parameters
Byale, Anjali , Simrén, Magnus , Tack, Jan , Nevé, Boris Le , Hassouna, Rim , Bangdiwala, Shrikant I. , Drossman, Douglas A. , Grover, Madhusudan , Palsson, Olafur S , Simrén, Magnus , Tack, Jan , Le Nevé, Boris , Hassouna, Rim , Bangdiwala, Shrikant , Sperber, Ami D , Drossman, Douglas , Grover, Madhusudan , Palsson, Olafur S.

American Journal of Gastroenterology | July 2, 2025 | Volume: 121 | Issue: 3 | Pages: 754-766

10.14309/ajg.0000000000003622 | PMID 40600966 Get It

INTRODUCTION: Bloating, distention, and gas-related gastrointestinal (GI) symptoms are frequently reported by patients across the spectrum of disorders of gut-brain interaction (DGBI). We aimed to characterize these using latent class modeling in a large multinational survey. METHODS: A nationwide survey of adults in the United States, United Kingdom, and Mexico used quota sampling for demographic balance. It included Rome IV diagnostic questions, Intestinal Gas Questionnaire, Patient Health Questionnaires for anxiety and depression (PHQ-4) and somatization (PHQ-12), quality of life (PROMIS Global-10), and lifestyle questions. Latent class analysis was performed using “depmix” in RStudio 4.2.3. RESULTS: A total of 3,471 subjects experiencing bloating and/or distention (mean age 43 years, 57% female) were included. Using 42 demographic and pertinent clinical variables, latent class analysis revealed 6 distinct clusters. The first 2 clusters demonstrated limited-to-moderate impairment in health-related quality of life (HRQoL), with both characterized by some degree of dietary and supplement associations; however, cluster 2 lacked specific triggers observed in other clusters. The subsequent 2 clusters showed favorable HRQoL and mild gas-related symptoms, with only cluster 4 exhibiting distinct dietary triggers. The final 2 clusters, associated with bowel dysfunction, showed a higher prevalence of irritable bowel syndrome (IBS) with constipation and IBS mixed in cluster 5, and IBS with diarrhea in cluster 6. These bowel dysfunction clusters exhibited severe gas symptoms in the preceding 24 hours and greater HRQoL impairment compared with the other 4 clusters. Notably, cluster 5 was linked to dietary triggers, whereas cluster 6 was defined by psychosocial comorbidities. DISCUSSION: Bloating and distention patients are likely driven by variable influences of dietary, psychological, and bowel dysfunction. Further studies are needed to identify mechanisms and titrate treatment suited to specific mechanistic drivers.
A Retrospective Study Identifying Factors Associated with Long-Term Survival in Lung Transplant Recipients: A Focus on Psychosocial Wellbeing and Social Determinants of Health
Huang, Eric , Saddoughi, Sahar A. , Yadav, Hemang , Pennington, Kelly M. , Kennedy, Cassie C.

Respiratory The American Medical Journal | July 2, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.33590/respiramj/fajf6685 Get It

Self-management interventions to improve health outcomes in youth living with congenital heart disease: a systematic review and narrative synthesis
Loor-Torres, Ricardo , Chavez, Maria Mateo , Boehmer, Kasey R. , Pardo, Laura Suarez, Connolly, Heidi M. , Egbe, Alexander C. , Passalacqua, Kelli, Kosec, Angela M, Burchill, Luke J. , Loor-Torres, Ricardo J , Mateo Chavez, Maria B , Boehmer, Kasey R , Suarez Pardo, Laura, Burchill, Luke J , Kosec, Angela M

European Journal of Cardiovascular Nursing | July 2, 2025 | Volume: 24 | Issue: 8 | Pages: 1225-1234

10.1093/eurjcn/zvaf129 | PMID 40605622 Get It

Abstract Aims Congenital heart disease (CHD) presents lifelong challenges that require effective self-management skills, particularly for youth transitioning to adulthood. This systematic review evaluates the impact of self-management interventions, grounded in self-efficacy, on both health and patient-reported outcomes in youths with CHD. Methods and results Adhering to Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines, we conducted a systematic review and registered the protocol in PROSPERO. We included interventional studies targeting youth aged 15–24 years with CHD that employed self-management interventions based on self-efficacy. Comprehensive searches were performed in Ovid MEDLINE, Ovid EMBASE, CINAHL, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and Scopus from January 1973 to March 2024, with an update to include studies published until December 2024. Two reviewers independently screened titles, abstracts, and full texts, resolving disagreements by consensus. Data extraction followed Template for Intervention Description and Replication guidelines, and risk of bias was assessed using the Cochrane Risk of Bias in Non-Randomized Studies of Interventions and Risk of Bias 2 tools. Out of 54 potential studies, 4 met the eligibility criteria, representing 150 patients aged 16–19 years. The studies reported improvements in condition-related knowledge, self-management skills, and social support, although data on clinical health outcomes were limited. A narrative synthesis of the selected interventions was performed. Conclusion Self-management interventions using self-efficacy frameworks show promise for improving patient-reported outcomes among youth with CHD. However, there is a scarcity of data on their impact on health outcomes. Further research is needed to develop and implement interventions tailored to this population, potentially improving both self-management and clinical outcomes. Registration PROSPERO: CRD42024499008
Design, Development, Funding, and Implementation of the CSRS Registry
Witham, Julie M., Sasso, Rick C., Mummaneni, Praveen V., Riew, K. Daniel , Sardar, Zeeshan M. , Ray, Wilson Z. , Harrop, James S., Protopsaltis, Themistocles S. , Nassr, Ahmad, Vedentam, Aditya, Rhee, John M. , Lawrence, Brandon D. , Ludwig, Steven C. , Ghogawala, Zoher , Mummaneni, Praveen V. , Riew, Kiehyun Daniel , Cho, Samuel K. , Mesfin, Addisu

Clinical Spine Surgery | July 2, 2025 | Volume: 39 | Issue: 3 | Pages: E153-E160

10.1097/bsd.0000000000001833 | PMID 40600728 Get It

Study Design: A national prospective cervical spine surgery registry was developed to archive radiographic studies, patient-reported outcome measures (PROMs), and surgical implant data to assess long-term safety. Objective: To describe the design, development, funding, and implementation of a cervical spine data registry for 1000 patients with myelopathy and radiculopathy. Summary of Background Data: While surgery for cervical radiculopathy and myelopathy is safe and effective, there is significant practice variation among spine surgeons. While randomized clinical trials (RCTs) can provide high-quality comparative effectiveness data, RCTs lack the ability to evaluate the safety and effectiveness of various surgical procedures and implants among heterogenous real-world patient populations. The CSRS Registry was designed to collect patient demographics, outcomes, radiographic imaging, surgical approach, and implant data for the purpose of conducting high-quality research. Methods: Patients with cervical myelopathy or radiculopathy were enrolled in the CSRS National Registry. De-identified patient data, validated PROMs, radiographic data, and implant data were collected from multiple clinical sites across the United States. Results: One thousand patients [mean age, 58 y; 456 (46%) women] were enrolled, with 31% follow-up at 1 year. Five hundred ninety-two patients were diagnosed with radiculopathy, 252 with myelopathy, and 156 with radiculopathy and myelopathy. Patients had significant improvements in their PROMs after surgery. At 1 year, the mean NDI score improved from 37.2 to 20.9 ( P <0.001). The mean self-reported P-mJOA score at baseline was 14.2 and improved to 15.2 by 1 year ( P <0.001). Baseline CSDI score was 23.6 and improved with a 1-year decrease to an average score of 13.6 ( P <0.001). There was significant improvement in PROMIS-10 Physical Health score from 41.0 to 45.9 (n=311; P <0.001) at 1-year follow-up. Conclusions: The CSRS Registry has successfully collected clinical outcomes data that is being leveraged for comparative effectiveness research and evaluations of the long-term safety and effectiveness of spinal implants.
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease
Farraye, Francis A. , Melmed, Gil , Lichtenstein, Gary R. , Limketkai, Berkeley N. , Kane, Sunanda V. , Farraye, Francis A , Melmed, Gil Y , Barnes, Edward L. , Caldera, Freddy

American Journal of Gastroenterology | July 2, 2025 | Volume: 120 | Issue: 7 | Pages: 1447-1473

10.14309/ajg.0000000000003541 | PMID 40701559 Get It

Patients with inflammatory bowel disease (IBD) often consider their gastroenterologist to be the primary provider of care. To improve the care delivered to patients with IBD, health maintenance issues need to be addressed by the gastroenterology team. In particular, documentation and recommendation for vaccinations are crucial because more than 70% of patients with IBD will at some time be on immune-modifying therapies that may increase the risk for infections, many of which are preventable with vaccinations. Health maintenance recommendations addressed in this guideline include the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, melanoma and non-melanoma skin cancer and screening for depression, anxiety, and need for smoking cessation. To accomplish these health maintenance goals, coordination among the primary care provider, gastroenterology team, and other specialists is necessary.